Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


Articles published in Nat Med

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    August 2021
  1. JABBARI E, Duff KE
    Tau-targeting antibody therapies: too late, wrong epitope or wrong target?
    Nat Med. 2021;27:1341-1342.
    PubMed    


    July 2021
  2. RABINOVICI GD
    Dominantly inherited Alzheimer's disease: a compass for drug development.
    Nat Med. 2021 Jul 5. pii: 10.1038/s41591-021-01434.
    PubMed    


    June 2021
  3. SALLOWAY S, Farlow M, McDade E, Clifford DB, et al
    A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.
    Nat Med. 2021 Jun 21. pii: 10.1038/s41591-021-01369.
    PubMed     Abstract available


  4. HANSSON O
    Biomarkers for neurodegenerative diseases.
    Nat Med. 2021;27:954-963.
    PubMed     Abstract available


    May 2021
  5. PALMQVIST S, Tideman P, Cullen N, Zetterberg H, et al
    Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures.
    Nat Med. 2021 May 24. pii: 10.1038/s41591-021-01348.
    PubMed     Abstract available


    April 2021
  6. VOGEL JW, Young AL, Oxtoby NP, Smith R, et al
    Four distinct trajectories of tau deposition identified in Alzheimer's disease.
    Nat Med. 2021 Apr 29. pii: 10.1038/s41591-021-01309.
    PubMed     Abstract available


    January 2021
  7. DUJARDIN S, Commins C, Lathuiliere A, Beerepoot P, et al
    Author Correction: Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.
    Nat Med. 2021 Jan 29. pii: 10.1038/s41591-021-01251.
    PubMed    


    November 2020
  8. ARNOLD C
    Post-hoc analysis could give new life to the Alzheimer's drug aducanumab.
    Nat Med. 2020 Nov 2. pii: 10.1038/d41591-020-00031.
    PubMed    


    June 2020
  9. DUJARDIN S, Commins C, Lathuiliere A, Beerepoot P, et al
    Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.
    Nat Med. 2020 Jun 22. pii: 10.1038/s41591-020-0938.
    PubMed     Abstract available


    May 2020
  10. ZHOU Y, Song WM, Andhey PS, Swain A, et al
    Author Correction: Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease.
    Nat Med. 2020 May 14. pii: 10.1038/s41591-020-0922.
    PubMed     Abstract available


    April 2020
  11. JOHNSON ECB, Dammer EB, Duong DM, Ping L, et al
    Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.
    Nat Med. 2020 Apr 13. pii: 10.1038/s41591-020-0815.
    PubMed     Abstract available


    March 2020
  12. BATEMAN RJ, Barthelemy NR, Horie K
    Another step forward in blood-based diagnostics for Alzheimer's disease.
    Nat Med. 2020 Mar 4. pii: 10.1038/s41591-020-0797.
    PubMed    


  13. THIJSSEN EH, La Joie R, Wolf A, Strom A, et al
    Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.
    Nat Med. 2020 Mar 2. pii: 10.1038/s41591-020-0762.
    PubMed     Abstract available


  14. JANELIDZE S, Mattsson N, Palmqvist S, Smith R, et al
    Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.
    Nat Med. 2020 Mar 2. pii: 10.1038/s41591-020-0755.
    PubMed     Abstract available


  15. BARTHELEMY NR, Li Y, Joseph-Mathurin N, Gordon BA, et al
    A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.
    Nat Med. 2020;26:398-407.
    PubMed     Abstract available


    January 2020
  16. ZHOU Y, Song WM, Andhey PS, Swain A, et al
    Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease.
    Nat Med. 2020;26:131-142.
    PubMed     Abstract available


    November 2019
  17. ARBOLEDA-VELASQUEZ JF, Lopera F, O'Hare M, Delgado-Tirado S, et al
    Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.
    Nat Med. 2019 Nov 4. pii: 10.1038/s41591-019-0611.
    PubMed     Abstract available


  18. ZALOCUSKY KA, Nelson MR, Huang Y
    An Alzheimer's-disease-protective APOE mutation.
    Nat Med. 2019 Nov 4. pii: 10.1038/s41591-019-0634.
    PubMed    


    May 2019
  19. STOWER H
    Improving cognition.
    Nat Med. 2019;25:710.
    PubMed    


    April 2019
  20. STEINER E, Tata M, Frisen J
    A fresh look at adult neurogenesis.
    Nat Med. 2019;25:542-543.
    PubMed    


    March 2019
  21. MORENO-JIMENEZ EP, Flor-Garcia M, Terreros-Roncal J, Rabano A, et al
    Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease.
    Nat Med. 2019 Mar 25. pii: 10.1038/s41591-019-0375.
    PubMed     Abstract available


  22. STOWER H
    Linking Alzheimer's disease and frailty.
    Nat Med. 2019 Mar 6. pii: 10.1038/s41591-019-0399.
    PubMed    


    February 2019
  23. ZETTERBERG H, Schott JM
    Biomarkers for Alzheimer's disease beyond amyloid and tau.
    Nat Med. 2019;25:201-203.
    PubMed    


  24. STOWER H
    Transmission of Abeta seeds.
    Nat Med. 2019;25:197.
    PubMed    


    January 2019
  25. PREISCHE O, Schultz SA, Apel A, Kuhle J, et al
    Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease.
    Nat Med. 2019 Jan 21. pii: 10.1038/s41591-018-0304.
    PubMed     Abstract available


  26. LOURENCO MV, Frozza RL, de Freitas GB, Zhang H, et al
    Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models.
    Nat Med. 2019;25:165-175.
    PubMed     Abstract available


  27. CHEN X, Gan L
    An exercise-induced messenger boosts memory in Alzheimer's disease.
    Nat Med. 2019;25:20-21.
    PubMed    


    December 2018
  28. STOWER H
    Meningeal lymphatics in aging and Alzheimer's disease.
    Nat Med. 2018;24:1781.
    PubMed    


    July 2018
  29. STOWER H
    Searching for Alzheimer's disease therapies.
    Nat Med. 2018;24:894-897.
    PubMed    


    May 2018
  30. SANCHEZ-MUT JV, Heyn H, Silva BA, Dixsaut L, et al
    PM20D1 is a quantitative trait locus associated with Alzheimer's disease.
    Nat Med. 2018 May 7. pii: 10.1038/s41591-018-0013.
    PubMed     Abstract available


    April 2018
  31. CHAKRADHAR S
    A tale of two diseases: Aging HIV patients inspire a closer look at Alzheimer's disease.
    Nat Med. 2018;24:376-377.
    PubMed    


    December 2017
  32. HE Z, Guo JL, McBride JD, Narasimhan S, et al
    Amyloid-beta plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.
    Nat Med. 2017 Dec 4. pii: nm.4443. doi: 10.1038/nm.4443.
    PubMed     Abstract available


    September 2017
  33. SALTER MW, Stevens B
    Microglia emerge as central players in brain disease.
    Nat Med. 2017;23:1018-1027.
    PubMed     Abstract available


    May 2017
  34. LAM AD, Deck G, Goldman A, Eskandar EN, et al
    Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease.
    Nat Med. 2017 May 1. doi: 10.1038/nm.4330.
    PubMed     Abstract available


    February 2017
  35. WONG YC, Krainc D
    alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies.
    Nat Med. 2017;23:1-13.
    PubMed     Abstract available


    October 2016
  36. KINCAID E
    Picture imperfect: Going beyond imaging amyloid in Alzheimer's disease.
    Nat Med. 2016;22:1067-1068.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: